We have collected information about Drug Delivery Visceral Leishmaniasis for you. Follow the links to find out details on Drug Delivery Visceral Leishmaniasis.
https://www.tandfonline.com/doi/abs/10.1517/17425240903548232
Importance of the field: Visceral leishmaniasis (VL) is the most overwhelming type of leishmaniasis associated with the poverty of developing countries and usually mortal if untreated. Most of the conventionally used dosage forms offer us the shortcomings of toxic side effects and emergence of drug resistance.Author: Swati Gupta, Ajay Pal, Suresh P Vyas
https://www.researchgate.net/profile/Swati_Gupta32/publication/41759257_Drug_delivery_strategies_for_therapy_of_visceral_leishmaniasis/links/5583c73408ae8bf4ba6fa533/Drug-delivery-strategies-for-therapy-of-visceral-leishmaniasis.pdf
maniasis. Visceral leishmaniasis (VL) is the most severe of all the forms of leishmaniasis and usually lethal if left untreated. The affected sites are the macro-
https://www.sciencedaily.com/releases/2018/07/180726085645.htm
Jul 26, 2018 · A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world's major neglected diseases, has been discovered. Visceral leishmaniasis is a disease which kills tens of thousands of people every year, mainly among the poorest in the world.
https://www.researchgate.net/publication/41759257_Drug_delivery_strategies_for_therapy_of_visceral_leishmaniasis
Drug delivery strategies for therapy of visceral leishmaniasis Article · Literature Review (PDF Available) in Expert Opinion on Drug Delivery 7(3):371-402 · March 2010 with 239 Reads
https://www.sciencedirect.com/science/article/pii/S1201971211000865
Leishmaniasis represents a significant global burden and a great challenge to drug discovery and delivery, because of the intracellular nature and disseminated locations of the parasite. The potential of some colloidal drug carriers such as emulsions, liposomes, and nanoparticles is of great interest, mainly due to their versatile nature and attractive advantages in the context of parasitic diseases.Author: Tatiana S. Tiuman, Adriana O. Santos, Tânia Ueda-Nakamura, Benedito P. Dias Filho, Celso V. Nakamura
https://www.medscape.com/viewarticle/833626
Nov 07, 2019 · New drugs are required for the treatment of leishmaniasis because drug resistance within the endemic parasite population is limiting their efficacy. Repurposing existing antileishmanial drugs …
https://www.ncbi.nlm.nih.gov/pubmed/30601770
Polycaprolactone Antimony Nanoparticles as Drug Delivery System for Leishmaniasis. Sousa-Batista AJ(1), Cerqueira-Coutinho C(2), do Carmo FS(3), Albernaz MS(3), Santos-Oliveira R(4). Author information: (1)Institute of Biophysics Carlos Chagas Filho, …Author: Ariane de Jesus Sousa-Batista, Cristal Cerqueira-Coutinho, Fagner Santos do Carmo, Marta de Souza Al...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932479/
This study establishes a proof-of-concept that a tattoo device can target intra-dermal drug delivery against cutaneous leishmaniasis (CL). The selected drug is oleylphosphocholine (OlPC) formulated as liposomes, particles known to be prone to macrophage ingestion.Author: Marina Temi Shio, Marina Temi Shio, Marilene Paquet, Caroline Martel, Tom Bosschaerts, Stef Stienstr...
https://www.drugs.com/condition/leishmaniasis.html
43 rows · Drugs Used to Treat Leishmaniasis The following list of medications are in some way related …
Searching for Drug Delivery Visceral Leishmaniasis?
You can just click the links above. The data is collected for you.
